hit counter
Forian Inc. (FORA) Stock News Sentiment & Price - Sentifly
FORA - Sentifly


Profile

Watchlist

Your watchlist is empty. Go add some tickers to it!



Forian Inc. (FORA)

USA
Healthcare Information Services
NASDAQ
FORA Price and Sentiment
1MO
1D
Positive, Negative
Loading chart...
FORA Latest news
Benzinga
Neutral
Forian Inc. Announces Third Quarter Fiscal 2021 Financial Results
2021-11-11 20:27

Forian Inc. (NASDAQ:FORA), a provider of technology, analytics and science-driven data solutions for the healthcare and cannabis industries, announced its financial results for the fiscal quarter ended September 30, 2021. Third Quarter 2021 Financial Results

Seeking Alpha
Neutral
Forian Inc. (FORA) CEO Daniel Barton on Q3 2021 Results - Earnings Call Transcript
2021-11-11 18:15

Forian Inc. (FORA) CEO Daniel Barton on Q3 2021 Results - Earnings Call Transcript

GlobeNewsWire
Neutral
Forian Inc. Announces Third Quarter Fiscal 2021 Financial Results
2021-11-11 16:03

Third Quarter Revenue of $5.0 Million, Up $4.8 Million Year-Over-Year, Pro Forma Year-Over-Year Growth of 62%

Business Wire
Neutral
VerticalScope Announces Three Additional Acquisitions
2021-11-09 18:42

TORONTO--(BUSINESS WIRE)---- $FORA #VerticalScope--VerticalScope announces three additional acquisitions.

Business Wire
Neutral
VerticalScope Announces Third Quarter 2021 Financial Results
2021-11-09 18:42

TORONTO--(BUSINESS WIRE)---- $FORA #VerticalScope--VerticalScope Announces Third Quarter 2021 Financial Results

GlobeNewsWire
Neutral
Forian Inc. to Announce 2021 Third Quarter Results on November 11, 2021
2021-10-21 13:00

NEWTOWN, Pa., Oct. 21, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Forian Inc. (Nasdaq:FORA), a provider of software, data, and analytics-enabled services for the healthcare and cannabis industries, will announce its financial results for the three months ended September 30, 2021 on Thursday, November 11, 2021 after the close of the market. The Company will host a conference call at 4:30 p.m. (ET) on November 11, 2021 to discuss the results. To access the conference call, from the US dial (855) 940-5323 or for International calls dial (929) 517-0423, and enter Conference ID 2915339. This information is also available on our website at www.forian.com/investors. The earnings release along with a replay of the call promptly following its conclusion will be available at the same site.

Benzinga
Positive
Forian To Raise $24M Via Private Placement Of 3.5% Convertible Notes, Appoints New CFO
2021-09-02 11:19

Forian Inc. (NASDAQ:FORA) announced on Wednesday a $24 million valued private placement of 3.5% convertible notes. The company, which provides analytics services and software solutions to healthcare and cannabis industries, also revealed it has appointed Michael Vesey as the new Chief Financial Officer.

PRNewsWire
Neutral
Forian Inc. Announces $24 Million Private Placement of 3.5% Convertible Notes due 2025, Appoints New Chief Financial Officer
2021-09-01 16:15

NEWTOWN, Pa., Sept. 1, 2021 /PRNewswire/ -- Forian Inc. (NASDAQ: FORA), a provider of technology, analytics and data science driven solutions for the healthcare and cannabis industries, today announced the following: Convertible Notes Offering The Company has entered into a convertible note purchase agreement (the "Note Purchase Agreement") with a select group of institutional and accredited investors pursuant to which the Company will issue  $24,000,000 aggregate principal amount at 100% of par value of its 3.5% convertible notes due 2025 (the "Notes").

Benzinga
Positive
MindMed Teams Up With Forian To Improve Real-World Evidence Data To Help Psychiatric Patients
2021-08-24 11:18

Psychedelics-focused medicines company Mind Medicine Inc. (NASDAQ:MNMD), (NEO: MMED) announced Tuesday that it has teamed up with Forian Inc. (NASDAQ:FORA), a provider of evidence-based support for more comprehensive clinical and commercial decision-making. MindMed and Forian will collaborate to develop best practices for using real-world evidence ("RWE") information to help improve the health and lives of psychiatric patients.

PRNewsWire
Neutral
MindMed Announces Collaboration With Forian To Advance Development Of Personalized Psychiatry For Anxiety Disorders
2021-08-24 07:30

NEW YORK, Aug. 24, 2021 /PRNewswire/ -- Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (DE: MMQ) (the "Company"), a leading biotech company developing psychedelic-inspired therapies, has agreed to work with Forian Inc. (NASDAQ: FORA), a leading provider of evidence-based support for more comprehensive clinical and commercial decision-making. MindMed and Forian will collaborate to develop best practices for using real-world evidence ("RWE") information to help improve the health and lives of psychiatric patients.

Loading more news...